Ingevity Corporation (NGVT) Financials

EPS

Hollow marker is the consensus estimate; filled is the reported figure, colored by beat or miss.

Revenue

Outlined bar is the consensus estimate; solid is reported.

Results

Periods without a consensus estimate or a reported figure show a dash.

Period	EPS estimate	EPS actual	EPS surprise %	Revenue estimate	Revenue actual	Revenue surprise %
Q1 26	$0.83	$1.15	+38.6%	—	$258M	—
Q4 25	$0.65	$0.63	-3.1%	—	$255.1M	—
Q3 25	$1.35	$1.52	+12.6%	—	$333.1M	—
Q2 25	$1.16	$1.39	+19.8%	—	$365.1M	—
Q1 25	$0.74	$0.99	+33.8%	—	$284M	—
Q4 24	$0.31	$0.95	+206.5%	—	$298.8M	—
Q3 24	$0.88	$1.1	+25.0%	—	$376.9M	—
Q2 24	$1.04	$1.01	-2.9%	—	$390.6M	—
Q1 24	$0.25	$0.52	+108.0%	—	$340.1M	—
Q4 23	-$0.19	$0.21	+210.5%	—	$371.7M	—
Q3 23	$1.22	$1.21	-0.8%	—	$446M	—
Q2 23	$1.37	$1.41	+2.9%	—	$481.8M	—
Q1 23	$1.13	$1.09	-3.5%	—	$392.6M	—
Q4 22	$0.87	$0.57	-34.5%	—	$383.6M	—
Q3 22	$1.69	$2.09	+23.7%	—	$482M	—
Q2 22	$1.62	$1.73	+6.8%	—	$419.9M	—

EPS

Reported per-share earnings by fiscal year; the line turns dotted where reported figures end and the analyst consensus begins, with the shaded band marking the low–high range.

Revenue

Reported revenue by fiscal year; the line turns dotted where reported figures end and the analyst consensus begins, with the shaded band marking the low–high range.

Results

Periods without a consensus estimate or a reported figure show a dash.

Period	EPS estimate	EPS actual	EPS surprise %	Revenue estimate	Revenue actual	Revenue surprise %
FY25	—	-$4.61	—	—	$1.2B	—
FY24	—	-$11.8	—	—	$1.4B	—
FY23	—	-$0.15	—	—	$1.7B	—
FY22	—	$5.54	—	—	$1.7B

Total revenue

Reported revenue per period; the line is the change from the same period a year earlier, on its own left axis.

Period	FY16	FY17	FY18	FY19	FY20	FY21	FY22	FY23	FY24	FY25
Revenue	$908.3M	$972.4M	$1.1B	$1.3B	$1.2B	$1.4B	$1.7B	$1.7B	$1.4B	$1.2B
YoY change	-5.22%	+7.06%	+16.6%	+14.1%	-5.94%	+14.4%	+19.9%	+1.43%	-16.9%	-17%

Revenue and profits

Revenue, gross profit, operating income, and net income per period.

Condensed income statement

Click a row to chart it; unreported figures show a dash.

Period	FY16	FY17	FY18	FY19	FY20	FY21	FY22	FY23	FY24	FY25
Revenue	908.3M	972.4M	1.1B	1.3B	1.2B	1.4B	1.7B	1.7B	1.4B	1.2B
Cost of revenue	633.9M	643.4M	716.8M	810.9M	750.6M	878.7M	1.1B	1.2B	951.7M	706.1M
Gross profit	274.4M	329M	416.8M	482M	465.5M	512.8M	570.1M	471.9M	454.7M	461.5M
Gross margin	30.2%	33.8%	36.8%	37.3%	38.3%	36.9%	34.2%	27.9%	32.3%	39.5%
Research & development	17.6M	19.8M	21.5M	19.7M	22.6M	26.3M	30.3M	31.8M	28.1M	28.4M
Selling, general & administrative	96.4M	106.4M	132.4M	163.1M	149.4M	179.3M	198.8M	183.7M	166.7M	171.2M
Operating expenses	114M	126.2M	153.9M	182.8M	172M	205.6M	229.1M	215.5M	194.8M	199.6M
Operating income	160.4M	202.8M	262.9M	299.2M	293.5M	307.2M	341M	256.4M	259.9M	261.9M
Operating margin	17.7%	20.9%	23.2%	23.1%	24.1%	22.1%	20.4%	15.2%	18.5%	22.4%
Non-operating income, net	-55.5M	-12.2M	-11.3M	-24.4M	-16.2M	-96.7M	-15.4M	-179.5M	-704.6M	-330.1M
Pretax income	87M	174.8M	221.8M	227.9M	235.1M	162.8M	269.6M	-10.1M	-535.6M	-142.1M
Income tax	42.6M	29.6M	40M	44.2M	53.7M	44.7M	58M	-4.7M	-105.3M	8.2M
Net income	44.4M	145.2M	181.8M	183.7M	181.4M	118.1M	211.6M	-5.4M	-430.3M	-167.1M
Net margin	4.89%	14.9%	16%	14.2%	14.9%	8.49%	12.7%	-0.32%	-30.6%	-14.3%
EBITDA	196.6M	243.8M	325.8M	397.6M	386.9M	412.6M	445.8M	360.9M	355.8M	345.9M
EPS	0.83	3	4.02	4.39	4.51	2.97	5.54	-0.15	-11.8	-4.61
Diluted EPS	0.83	2.97	3.97	4.35	4.48	2.95	5.5	-0.15	-11.8	-4.61

Revenue and profits

Revenue, gross profit, operating income, and net income per period.

Condensed income statement

Click a row to chart it; unreported figures show a dash.

Period	Q3 23	Q4 23	Q1 24	Q2 24	Q3 24	Q4 24	Q1 25	Q2 25	Q3 25	Q4 25	Q1 26	Q2 26
Revenue	446M	371.7M	340.1M	390.6M	376.9M	298.8M	284M	365.1M	333.1M	255.1M	258M	314.1M
Cost of revenue	317M	312.2M	240.4M	267.4M	247M	196.9M	170.6M	227.2M	199.2M	167.3M	141.6M	175.1M
Gross profit	129M	59.5M	99.7M	123.2M	129.9M	101.9M	113.4M	137.9M	133.9M	87.8M	116.4M	139M
Gross margin	28.9%	16%	29.3%	31.5%	34.5%	34.1%	39.9%	37.8%	40.2%	34.4%	45.1%	44.3%
Research & development	7.8M	7.2M	6.8M	7.3M	6.7M	7.3M	7.7M	7.8M	7M	7.4M	6.7M	6.1M
Selling, general & administrative	40M	43.4M	47.2M	41.4M	38.7M	39.4M	43.1M	44.2M	44.1M	41.6M	40.7M	39M
Operating expenses	47.8M	50.6M	54M	48.7M	45.4M	46.7M	50.8M	52M	51.1M	49M	47.4M	45.1M
Operating income	81.2M	8.9M	45.7M	74.5M	84.5M	55.2M	62.6M	85.9M	82.8M	38.8M	69M	93.9M
Operating margin	18.2%	2.39%	13.4%	19.1%	22.4%	18.5%	22%	23.5%	24.9%	15.2%	26.7%	29.9%
Non-operating income, net	-26M	-140.2M	-95.3M	-385.9M	-198.2M	-25.2M	-16.2M	-209.7M	-2M	-127.4M	-23M	-29.1M
Pretax income	32.1M	-154M	-71.9M	-334.6M	-137.9M	8.8M	26.8M	-142.7M	62.2M	-105.4M	30.2M	50.7M
Income tax	6.9M	-37.2M	-15.9M	-50.9M	-30.7M	-7.8M	6.3M	3.8M	21.4M	-26.6M	6.8M	10.9M
Net income	25.2M	-116.8M	-56M	-283.7M	-107.2M	16.6M	20.5M	-146.5M	43.5M	-84.6M	59.8M	35.3M
Net margin	5.65%	-31.4%	-16.5%	-72.6%	-28.4%	5.56%	7.22%	-40.1%	13.1%	-33.2%	23.2%	11.2%
EBITDA	112.9M	1.2M	71.5M	99.9M	106.2M	74.6M	83.2M	108.2M	110.8M	51.8M	89.5M	113.7M
EPS	0.7	-3.23	-1.54	-7.81	-2.95	0.46	0.56	-4.02	1.2	-2.37	1.7	1.02
Diluted EPS	0.69	-3.23	-1.54	-7.81	-2.95	0.46	0.56	-4.02	1.18	-2.37	1.66	1

P/E

Annual history by fiscal year; click a table row below to chart a different metric.

Current values are trailing twelve months where available, otherwise the latest fiscal year; unreported figures show a dash.

Key stats

Metric	FY16	FY17	FY18	FY19	FY20	FY21	FY22	FY23	FY24	FY25	Current
Market cap	2.3B	3B	3.5B	3.7B	3.1B	2.9B	2.7B	1.7B	1.5B	2.1B	2.5B
Enterprise value	2.8B	3.3B	4.2B	4.9B	4.2B	3.9B	4.1B	3.2B	2.9B	3.3B	3.6B
Shares outstanding	42.1M	42.1M	42M	41.8M	41.3M	39.8M	38.2M	36.5M	36.3M	36.2M	36.2M

Valuation

Metric	FY16	FY17	FY18	FY19	FY20	FY21	FY22	FY23	FY24	FY25	Current
P/E	52	20.4	19.3	19.9	17.2	24.2	12.7	—	—	—	102.5
P/S	2.54	3.05	3.1	2.83	2.57	2.05	1.61	1.02	1.05	1.83	2.16
P/B	17.2	10.7	10.4	6.88	4.87	4.24	3.85	2.73	7.58	72.1	53.5
EV/EBITDA	14.1	13.7	12.9	12.3	10.9	9.46	9.3	8.76	8.05	9.56	9.79
EV/Sales	3.05	3.43	3.7	3.79	3.47	2.8	2.48	1.87	2.04	2.83	3.14
Earnings yield	1.92%	4.89%	5.17%	5.03%	5.8%	4.14%	7.86%	—	—	—	0.98%
FCF yield	3.08%	4.1%	4.5%	4.41%	7.88%	6.64%	6.35%	5.53%	3.45%	12.8%	3.56%
PEG	—	—	—	—	—	—	—	—	—	—	-0.82

Profitability

Metric	FY16	FY17	FY18	FY19	FY20	FY21	FY22	FY23	FY24	FY25	Current
Gross margin	30.2%	33.8%	36.8%	37.3%	38.3%	36.9%	34.2%	27.9%	32.3%	39.5%	44.3%
Operating margin	17.7%	20.9%	23.2%	23.1%	24.1%	22.1%	20.4%	15.2%	18.5%	22.4%	29.9%
Net margin	4.89%	14.9%	16%	14.2%	14.9%	8.49%	12.7%	-0.32%	-30.6%	-14.3%	4.65%
ROE	33%	52.2%	53.7%	34.6%	28.3%	17.5%	30.3%	-0.86%	-220.4%	-562.6%	30.1%
ROA	5.33%	15.6%	13.8%	8.58%	7.77%	4.78%	7.73%	-0.21%	-21.3%	-10.1%	10.4%
ROIC	13.8%	26.3%	21.3%	13.6%	13.1%	12.9%	12.4%	12.4%	16.4%	21.9%	16%
Return on tangible assets	5.75%	16.9%	23.8%	42.6%	27.9%	14.3%	26.9%	-0.68%	-42%	-13.8%	4.31%

Financial health

Metric	FY16	FY17	FY18	FY19	FY20	FY21	FY22	FY23	FY24	FY25	Current
Current ratio	2.16	2.41	2.31	2.15	2.81	2.7	2.25	1.81	1.87	1.33	1.61
Quick ratio	1.05	1.36	1.26	1.16	1.97	1.8	1.15	0.96	1.01	0.79	1.15
Debt / equity	3.63	1.63	2.22	2.46	2.09	1.96	2.19	2.43	7.45	41.8	26.4
Debt / assets	0.59	0.49	0.57	0.61	0.58	0.54	0.56	0.58	0.72	0.75	0.8
Net debt / EBITDA	2.33	1.49	2.07	3.14	2.81	2.54	3.26	3.99	3.9	3.37	3.11
Interest coverage	5.51	10.7	7.68	5.08	5.99	4.15	5.36	0.89	-4.48	-0.84	1.55
Effective tax rate	49%	16.9%	18%	19.4%	22.8%	27.5%	21.5%	0%	0%	0%	33.2%

Per share

Metric	FY16	FY17	FY18	FY19	FY20	FY21	FY22	FY23	FY24	FY25	Current
Revenue per share	21.6	23.1	27	30.9	29.4	35	43.7	46.4	38.7	32.3	32.7
EPS (basic)	0.83	3	4.02	4.39	4.51	2.97	5.54	-0.15	-11.8	-4.61	-4.61
EPS (diluted)	0.83	2.97	3.97	4.35	4.48	2.95	5.5	-0.15	-11.8	-4.61	0.71
Book value per share	3.2	6.6	8.06	12.7	15.5	16.9	18.3	17.3	5.38	0.82	1.36
FCF per share	1.69	2.89	3.76	3.85	5.97	4.76	4.47	2.61	1.4	7.56	4.39
Cash per share	0.72	2.13	1.85	1.36	6.24	6.92	2.01	2.63	1.87	2.16	2.83
Capex per share	—	—	0	0	0.58	—	—	—	—	1.59	1.59

Capital allocation

Metric	FY16	FY17	FY18	FY19	FY20	FY21	FY22	FY23	FY24	FY25	Current
Capex / revenue	—	—	0%	0%	1.96%	—	—	—	—	4.94%	4.83%
Capex / operating cash flow	—	—	0%	0%	7.55%	—	—	—	—	17.4%	26.6%
Payout ratio	—	—	—	—	—	—	—	—	—	—	0%

Period	Q3 23	Q4 23	Q1 24	Q2 24	Q3 24	Q4 24	Q1 25	Q2 25	Q3 25	Q4 25	Q1 26	Q2 26
Revenue	$446M	$371.7M	$340.1M	$390.6M	$376.9M	$298.8M	$284M	$365.1M	$333.1M	$255.1M	$258M	$314.1M
YoY change	-7.47%	-3.1%	-13.4%	-18.9%	-15.5%	-19.6%	-16.5%	-6.53%	-11.6%	-14.6%	-9.15%	-14%

Assets vs. liabilities & equity

What the company owns (left stack) against what it owes plus shareholders' equity (right stack). The two stacks should match — that's the balance.

Condensed balance sheet

Click a row to chart it; unreported figures show a dash.

Period	FY16	FY17	FY18	FY19	FY20	FY21	FY22	FY23	FY24	FY25
Cash & short-term investments	30.5M	89.7M	77.9M	56.9M	257.7M	275.4M	76.7M	95.9M	68M	78.1M
Receivables	89.8M	100M	118.9M	150M	148M	161.7M	224.8M	182M	141M	127.2M
Inventory	151.2M	160M	191.4M	212.5M	189M	241.2M	335M	308.8M	226.8M	186M
Total current assets	295.2M	368.7M	422.7M	463.2M	628.7M	724.9M	683.3M	658.6M	493.2M	454.2M
Property, plant & equipment	311.6M	323.5M	410.7M	601.2M	578.7M	594.9M	654.3M	611.9M	485M	425.1M
Goodwill & intangibles	61M	71.6M	552.2M	1.7B	1.7B	1.6B	1.9B	1.8B	998.2M	439.6M
Total assets	832.8M	929.6M	1.3B	2.1B	2.3B	2.5B	2.7B	2.6B	2B	1.7B
Accounts payable	79.2M	83.1M	92.9M	99.1M	104.2M	125.8M	174.8M	158.4M	94.5M	92M
Short-term debt	7.5M	9.4M	11.2M	39.6M	42.2M	37M	17.4M	103.1M	78.2M	58.9M
Total current liabilities	136.9M	153.2M	183.3M	215.5M	223.4M	268.9M	303.5M	362.9M	264.1M	341.3M
Long-term debt	481.3M	444M	741.2M	1.3B	1.3B	1.3B	1.5B	1.4B	1.4B	1.2B
Total liabilities	698.2M	651.7M	976.5M	1.6B	1.7B	1.8B	2B	2B	1.8B	1.6B
Shareholders' equity	134.6M	277.9M	338.7M	530.8M	642.1M	673.8M	698.3M	631.4M	195.2M	29.7M
Total debt	488.8M	453.4M	752.4M	1.3B	1.3B	1.3B	1.5B	1.5B	1.5B	1.2B
Net debt	458.3M	365.5M	674.9M	1.2B	1.1B	1B	1.5B	1.4B	1.4B	1.2B

Assets vs. liabilities & equity

What the company owns (left stack) against what it owes plus shareholders' equity (right stack). The two stacks should match — that's the balance.

Condensed balance sheet

Click a row to chart it; unreported figures show a dash.

Period	Q3 23	Q4 23	Q1 24	Q2 24	Q3 24	Q4 24	Q1 25	Q2 25	Q3 25	Q4 25	Q1 26	Q2 26
Cash & short-term investments	84.5M	95.9M	88.5M	107.4M	135.5M	68M	71.5M	76.9M	83.4M	78.1M	95.4M	97.4M
Receivables	216.6M	182M	191.3M	213.4M	189.9M	141M	163.7M	193.4M	168.1M	127.2M	151.2M	155.8M
Inventory	386.7M	308.8M	325.5M	302M	261M	226.8M	245.4M	220.3M	193.7M	186M	203.6M	154M
Total current assets	734.5M	658.6M	669.2M	685.8M	636.8M	493.2M	530M	536M	522.2M	454.2M	581.8M	543.8M
Property, plant & equipment	658.2M	611.9M	572.7M	561.8M	504.7M	485M	472.6M	462.9M	422.6M	425.1M	421.6M	414M
Goodwill & intangibles	1.8B	1.8B	1.7B	945.4M	971M	998.2M	915M	566.8M	543.8M	439.6M	344.6M	283.2M
Total assets	2.8B	2.6B	2.6B	2.3B	2.2B	2B	2.1B	1.9B	1.8B	1.7B	1.7B	1.5B
Accounts payable	197.3M	158.4M	153.1M	142.4M	96.5M	94.5M	108.3M	101.5M	100.9M	92M	85M	88M
Short-term debt	21.4M	103.1M	103.5M	121.5M	118.9M	78.2M	76.2M	109.5M	112.1M	58.9M	135.2M	156.2M
Total current liabilities	305.1M	362.9M	351.7M	357.8M	360.8M	264.1M	264.6M	393.1M	411.6M	341.3M	409.4M	337.6M
Long-term debt	1.5B	1.4B	1.5B	1.4B	1.4B	1.4B	1.4B	1.3B	1.2B	1.2B	1.1B	1.1B
Total liabilities	2B	2B	2B	2B	2B	1.8B	1.8B	1.8B	1.7B	1.6B	1.6B	1.5B
Shareholders' equity	718.7M	631.4M	568.2M	284.8M	214.5M	195.2M	234.6M	120.7M	138.1M	29.7M	38.9M	46.9M
Total debt	1.5B	1.5B	1.6B	1.6B	1.6B	1.5B	1.4B	1.4B	1.3B	1.2B	1.2B	1.2B
Net debt	1.5B	1.4B	1.5B	1.5B	1.4B	1.4B	1.4B	1.3B	1.2B	1.2B	1.1B	1.1B

Cash generation and uses

Cash from operations, what's left after capex, and what went back to shareholders. Bars below the line are cash going out.

Condensed cash flow statement

Click a row to chart it; unreported figures show a dash.

Period	FY16	FY17	FY18	FY19	FY20	FY21	FY22	FY23	FY24	FY25
Net income	44.4M	145.2M	181.8M	183.7M	181.4M	118.1M	211.6M	-5.4M	-430.3M	-167.1M
Depreciation & amortization	38.8M	40.4M	57M	85M	100.2M	109.9M	108.8M	122.8M	108.3M	106.4M
Stock-based compensation	4.7M	10.1M	12.5M	12.3M	8.4M	12.3M	16.1M	10.6M	11.9M	18.3M
Change in working capital	5.7M	-24.2M	-19.8M	-49.4M	-18.9M	8.5M	-62.8M	-45.5M	-14.9M	28.6M
Operating cash flow	116.5M	149.3M	239.8M	270.2M	315.3M	265M	294.1M	193.4M	-230.7M	331.2M
Capital expenditure	—	—	0	0	-23.8M	—	—	—	—	-57.7M
Investing cash flow	-69.7M	-6M	-320.5M	-543.5M	-28.5M	-34.8M	-409.4M	32.5M	-1.9M	-57.5M
Dividends paid	—	—	—	—	—	—	—	—	—	—
Share repurchases	0	-6.6M	-47.4M	-6.4M	-88M	-109.4M	-145.2M	-92.1M	0	-56.3M
Financing cash flow	-12.8M	-58.3M	151.6M	-301.3M	-81.3M	-139M	44.9M	-103.9M	-69.2M	-252.3M
Net change in cash	34M	85M	70.9M	-574.6M	205.5M	91.2M	-70.4M	122M	-301.8M	21.4M
Free cash flow	71.2M	121.7M	158.1M	160.9M	246.5M	189.5M	170.9M	95.3M	51M	273.5M

Cash generation and uses

Cash from operations, what's left after capex, and what went back to shareholders. Bars below the line are cash going out.

Condensed cash flow statement

Click a row to chart it; unreported figures show a dash.

Period	Q3 23	Q4 23	Q1 24	Q2 24	Q3 24	Q4 24	Q1 25	Q2 25	Q3 25	Q4 25	Q1 26	Q2 26
Net income	25.2M	-116.8M	-56M	-283.7M	-107.2M	16.6M	20.5M	-146.5M	43.5M	-84.6M	59.8M	35.3M
Depreciation & amortization	30.6M	25.1M	29.6M	27.3M	26.2M	25.2M	24.9M	25.6M	28M	27.9M	22.7M	22M
Stock-based compensation	-600K	2.3M	4.3M	2.4M	3.1M	2.1M	4.1M	4.4M	5.3M	4.5M	4.8M	4.2M
Change in working capital	8.5M	60.1M	-54M	8.7M	25.2M	24.8M	-21M	-1.2M	10.6M	40.1M	-61.9M	200K
Operating cash flow	77.6M	55.3M	-31M	-373.1M	-14.1M	126M	32.7M	79M	129.7M	97.1M	-2M	-13.8M
Capital expenditure	—	—	—	—	—	—	—	-12.2M	-11.9M	-23.6M	-10.3M	-10.3M
Investing cash flow	3.6M	8.2M	300K	300K	600K	-3.1M	-1.5M	-2.8M	-7.1M	-28.1M	106.3M	75.4M
Dividends paid	—	—	—	—	—	—	—	—	—	—	—	—
Share repurchases	0	0	0	0	0	0	—	—	-25.2M	-31.1M	-52.3M	-34.5M
Financing cash flow	-107.6M	-142.6M	-31.2M	-21M	-6.3M	-96.6M	-110.9M	-129.6M	-95.4M	-82.9M	-782.8M	-204.1M
Net change in cash	-26.4M	-79.1M	-61.9M	-393.8M	-19.8M	26.3M	-79.7M	-53.4M	27.2M	-13.9M	-678.5M	-142.5M
Free cash flow	71.7M	15.4M	-28.7M	11.6M	28.5M	39.6M	15.4M	66.8M	117.8M	73.5M	-12.3M	-24.1M

Ingevity Corporation Financials

EPS

Revenue

Results

EPS

Revenue

Results

Total revenue

Total revenue

Revenue and profits

Condensed income statement

Revenue and profits

Condensed income statement

P/E

Key stats

Valuation

Profitability

Financial health

Per share

Capital allocation

Assets vs. liabilities & equity

Condensed balance sheet

Assets vs. liabilities & equity

Condensed balance sheet

Cash generation and uses

Condensed cash flow statement

Cash generation and uses

Condensed cash flow statement